Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Keratosis, Actinic 5Neoplasms 4Urinary Bladder Neoplasms 1Squamous Intraepithelial Lesions 1Solid Tumors Harboring NTRK Fusion 1Skin Neoplasms 1Rectal Neoplasms 1Polycystic Ovary Syndrome 1Pain 1Obesity 1Nonmelanoma Skin Cancers 1Neoplasm Metastasis 1Mucositis 1Lung Neoplasms 1Leukemia 1Invasive Fungal Infections 1Infertility, Female 1Infertility 1Inappropriate Prescribing 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1Basal Cell Nevus Syndrome 1Anemia 1Advanced Solid Tumors 1Adenocarcinoma of Lung 1

Interventions

durvalumab 7Carboplatin 7Docetaxel 6Paclitaxel 5Nivolumab 5talazoparib 4linifanib 4Cisplatin 4trifluridine tipiracil drug combination 3tremelimumab 3tislelizumab 3depatuxizumab 3ST 1481 3S 1 (combination) 3Panobinostat 3Gemcitabine 3zimberelimab 2toripalimab 2olaparib 2motesanib diphosphate 2mogamulizumab 2TAS-114 2Sorafenib 2Rifampin 2PM 01183 2Oxaliplatin 2MLN 8237 2Itraconazole 2Injections 2Erlotinib Hydrochloride 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Solid Tumors × Solutions × Clear all
NCT02031055 2024-09-05

Study of the Mass Balance of Oral FTD and TPI as Components of TAS-102 in Patients With Advanced Solid Tumors

Taiho Oncology, Inc.

Phase 1 Completed
8 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡